rs78461695

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_201384.3(PLEC):​c.11720C>T​(p.Thr3907Met) variant causes a missense change. The variant allele was found at a frequency of 0.00926 in 1,596,684 control chromosomes in the GnomAD database, including 75 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T3907T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0077 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0094 ( 69 hom. )

Consequence

PLEC
NM_201384.3 missense

Scores

8
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 5.10

Publications

9 publications found
Variant links:
Genes affected
PLEC (HGNC:9069): (plectin) Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, and 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as "hemidesmosomal protein 1" or "plectin 1, intermediate filament binding 500kDa". These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5' transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin's highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5' exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (PMID:10556294), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). The short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used. [provided by RefSeq, Aug 2011]
PLEC Gene-Disease associations (from GenCC):
  • PLEC-related muscular dystrophy-epidermolysis bullosa simplex spectrum disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • epidermolysis bullosa simplex
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • epidermolysis bullosa simplex 5A, Ogna type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • autosomal recessive limb-girdle muscular dystrophy type 2Q
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • congenital myasthenic syndrome
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • epidermolysis bullosa simplex 5B, with muscular dystrophy
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • epidermolysis bullosa simplex 5C, with pyloric atresia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • aplasia cutis congenita
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cholestasis
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0072327554).
BP6
Variant 8-143918101-G-A is Benign according to our data. Variant chr8-143918101-G-A is described in ClinVar as Benign. ClinVar VariationId is 196812.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00765 (1165/152272) while in subpopulation AMR AF = 0.0133 (203/15308). AF 95% confidence interval is 0.0118. There are 6 homozygotes in GnomAd4. There are 516 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLEC
NM_201384.3
MANE Select
c.11720C>Tp.Thr3907Met
missense
Exon 32 of 32NP_958786.1Q15149-4
PLEC
NM_201378.4
MANE Plus Clinical
c.11678C>Tp.Thr3893Met
missense
Exon 32 of 32NP_958780.1Q15149-9
PLEC
NM_201380.4
c.12131C>Tp.Thr4044Met
missense
Exon 32 of 32NP_958782.1Q15149-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLEC
ENST00000345136.8
TSL:1 MANE Select
c.11720C>Tp.Thr3907Met
missense
Exon 32 of 32ENSP00000344848.3Q15149-4
PLEC
ENST00000356346.7
TSL:1 MANE Plus Clinical
c.11678C>Tp.Thr3893Met
missense
Exon 32 of 32ENSP00000348702.3Q15149-9
PLEC
ENST00000322810.8
TSL:1
c.12131C>Tp.Thr4044Met
missense
Exon 32 of 32ENSP00000323856.4Q15149-1

Frequencies

GnomAD3 genomes
AF:
0.00766
AC:
1165
AN:
152154
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00212
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0133
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00339
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0116
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.00775
AC:
1690
AN:
218106
AF XY:
0.00762
show subpopulations
Gnomad AFR exome
AF:
0.00204
Gnomad AMR exome
AF:
0.00897
Gnomad ASJ exome
AF:
0.00564
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00434
Gnomad NFE exome
AF:
0.0115
Gnomad OTH exome
AF:
0.0117
GnomAD4 exome
AF:
0.00943
AC:
13626
AN:
1444412
Hom.:
69
Cov.:
57
AF XY:
0.00923
AC XY:
6631
AN XY:
718258
show subpopulations
African (AFR)
AF:
0.00150
AC:
50
AN:
33302
American (AMR)
AF:
0.00924
AC:
401
AN:
43394
Ashkenazi Jewish (ASJ)
AF:
0.00503
AC:
130
AN:
25862
East Asian (EAS)
AF:
0.0000763
AC:
3
AN:
39334
South Asian (SAS)
AF:
0.00230
AC:
196
AN:
85166
European-Finnish (FIN)
AF:
0.00475
AC:
208
AN:
43756
Middle Eastern (MID)
AF:
0.00226
AC:
13
AN:
5748
European-Non Finnish (NFE)
AF:
0.0109
AC:
12064
AN:
1107912
Other (OTH)
AF:
0.00936
AC:
561
AN:
59938
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
882
1764
2646
3528
4410
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
424
848
1272
1696
2120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00765
AC:
1165
AN:
152272
Hom.:
6
Cov.:
32
AF XY:
0.00693
AC XY:
516
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00212
AC:
88
AN:
41562
American (AMR)
AF:
0.0133
AC:
203
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5168
South Asian (SAS)
AF:
0.000830
AC:
4
AN:
4822
European-Finnish (FIN)
AF:
0.00339
AC:
36
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0116
AC:
792
AN:
68002
Other (OTH)
AF:
0.00851
AC:
18
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
59
119
178
238
297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00847
Hom.:
7
Bravo
AF:
0.00793
TwinsUK
AF:
0.0116
AC:
43
ALSPAC
AF:
0.00778
AC:
30
ESP6500AA
AF:
0.000730
AC:
3
ESP6500EA
AF:
0.0107
AC:
90
ExAC
AF:
0.00723
AC:
870
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
4
not specified (4)
-
-
1
Epidermolysis bullosa simplex, Ogna type;C2677349:Epidermolysis bullosa simplex 5C, with pyloric atresia;C2931072:Epidermolysis bullosa simplex 5B, with muscular dystrophy;C3150989:Autosomal recessive limb-girdle muscular dystrophy type 2Q;C4225309:Epidermolysis bullosa simplex with nail dystrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.30
CADD
Uncertain
24
DANN
Benign
0.95
DEOGEN2
Benign
0.32
T
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.93
D
MetaRNN
Benign
0.0072
T
MetaSVM
Benign
-0.31
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
5.1
PrimateAI
Benign
0.44
T
PROVEAN
Uncertain
-2.8
D
REVEL
Benign
0.28
Sift
Uncertain
0.018
D
Sift4G
Uncertain
0.033
D
Polyphen
1.0
D
Vest4
0.32
MVP
0.77
ClinPred
0.016
T
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.11
gMVP
0.64
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78461695; hg19: chr8-144992269; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.